SCHEMBL8107893

SCHEMBL8107893

NC1CCN(Cc2ccc(F)cc2F)CC1.NC1CCN(Cc2ccc(F)cc2F)CC1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
ALDH1A1 P00352 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
BCHE P06276 2/20 0.54
ACHE P22303 2/20 0.54
BACE1 P56817 2/20 0.54
CXCR3 P49682 3/20 0.49
SIGMAR1 Q99720 1/20 0.47
HTR2A P28223 2/20 0.45
HTR2C P28335 2/20 0.45
KCNH2 Q12809 2/20 0.45
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44
TYK2 P29597 1/20 0.44
JAK3 P52333 1/20 0.44
DRD2 P14416 1/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948669 1.00 KDM4E (0.66) KDM4ESMN1; SMN2ALDH1A1TDP1BCHE
SCHEMBL6947670 0.87 KDM4E (0.49) KDM4ESMN1; SMN2ALDH1A1TDP1BCHE
SCHEMBL8109203 0.87 KDM4E (0.49) KDM4ESMN1; SMN2ALDH1A1TDP1BCHE
SCHEMBL3149917 0.84 CXCR3 (0.65) CXCR3
SCHEMBL6944544 0.84 ACHE (0.48) KDM4ESMN1; SMN2ALDH1A1ACHEJAK2
SCHEMBL23775458 0.84 OPRM1 (0.51) KDM4ESMN1; SMN2ALDH1A1TDP1BCHE
SCHEMBL20600701 0.84 KDM4E (0.62) KDM4ESMN1; SMN2ALDH1A1TDP1BCHE
SCHEMBL13375732 0.81 KDM4E (0.62) KDM4ESMN1; SMN2ALDH1A1TDP1BCHE
SCHEMBL3150259 0.81 DPP4 (0.47) KDM4ESMN1; SMN2ALDH1A1TDP1BCHE
SCHEMBL16731628 0.81 KDM4E (0.89) KDM4ESMN1; SMN2ALDH1A1TDP1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056744-A1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043675-A1 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed